Respiri Limited

ASX:RSH Stock Report

Market Cap: AU$38.2m

Respiri Management

Management criteria checks 3/4

Respiri's CEO is Marjan Mikel, appointed in Dec 2019, has a tenure of 4.33 years. total yearly compensation is A$569.92K, comprised of 75.2% salary and 24.8% bonuses, including company stock and options. directly owns 0.43% of the company’s shares, worth A$164.11K. The average tenure of the management team and the board of directors is 2.8 years and 1.2 years respectively.

Key information

Marjan Mikel

Chief executive officer

AU$569.9k

Total compensation

CEO salary percentage75.2%
CEO tenure4.3yrs
CEO ownership0.4%
Management average tenure2.8yrs
Board average tenure1.2yrs

Recent management updates

Respiri Limited's (ASX:RSH) CEO Will Probably Find It Hard To See A Huge Raise This Year

Nov 08
Respiri Limited's (ASX:RSH) CEO Will Probably Find It Hard To See A Huge Raise This Year

Recent updates

Respiri Limited's (ASX:RSH) CEO Will Probably Find It Hard To See A Huge Raise This Year

Nov 08
Respiri Limited's (ASX:RSH) CEO Will Probably Find It Hard To See A Huge Raise This Year

We're Keeping An Eye On Respiri's (ASX:RSH) Cash Burn Rate

Aug 17
We're Keeping An Eye On Respiri's (ASX:RSH) Cash Burn Rate

Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation

Apr 29
Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation

Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation

Jan 03
Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation

Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation

Sep 21
Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation

We Think Respiri (ASX:RSH) Can Afford To Drive Business Growth

Jun 07
We Think Respiri (ASX:RSH) Can Afford To Drive Business Growth

Respiri (ASX:RSH) Is In A Good Position To Deliver On Growth Plans

Feb 22
Respiri (ASX:RSH) Is In A Good Position To Deliver On Growth Plans

CEO Compensation Analysis

How has Marjan Mikel's remuneration changed compared to Respiri's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$6m

Sep 30 2023n/an/a

-AU$6m

Jun 30 2023AU$570kAU$428k

-AU$6m

Mar 31 2023n/an/a

-AU$6m

Dec 31 2022n/an/a

-AU$6m

Sep 30 2022n/an/a

-AU$6m

Jun 30 2022AU$607kAU$428k

-AU$7m

Mar 31 2022n/an/a

-AU$7m

Dec 31 2021n/an/a

-AU$8m

Sep 30 2021n/an/a

-AU$9m

Jun 30 2021AU$2mAU$428k

-AU$11m

Mar 31 2021n/an/a

-AU$12m

Dec 31 2020n/an/a

-AU$12m

Sep 30 2020n/an/a

-AU$10m

Jun 30 2020AU$2mAU$187k

-AU$7m

Compensation vs Market: Marjan's total compensation ($USD365.52K) is about average for companies of similar size in the Australian market ($USD288.62K).

Compensation vs Earnings: Marjan's compensation has been consistent with company performance over the past year.

CEO

Marjan Mikel

4.3yrs

Tenure

AU$569,919

Compensation

Mr. Marjan Mikel, M.Com, BSc (Hons), Dip Ed, MAICD), serves as Chief Executive Officer and Managing Director at Respiri Limited since December 2, 2019 and serves as its Executive Director since November 25...

Leadership Team

NamePositionTenureCompensationOwnership
Nicholas Smedley
Executive Chairman4.5yrsAU$310.22k1.53%
A$ 585.4k
Marjan Mikel
CEO, MD & Executive Director4.3yrsAU$569.92k0.43%
A$ 164.1k
Peter Hildebrandt
Chief Operations Officer3.4yrsAU$293.97kno data
George Vlachodimitropoulos
Chief Technology Officer2.7yrsAU$282.60kno data
Samaneh Shirazi
Chief Research Officer5.2yrsAU$194.99kno data
Theo Antonopoulos
Chief Commercial Officer2.8yrsAU$322.14kno data
William Sigsbee
Head of US Operations & Chief Commercial Officerless than a yearno datano data
Justin Mouchacca
Joint Company Secretaryless than a yearno datano data
Nova Taylor
Joint Company Secretaryless than a yearno datano data
Noam Gavriely
Medical & Scientific Advisorno dataAU$310.61kno data
Simon Godfrey
Medical & Scientific Advisorno datano datano data

2.8yrs

Average Tenure

Experienced Management: RSH's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Nicholas Smedley
Executive Chairman4.5yrsAU$310.22k1.53%
A$ 585.4k
Marjan Mikel
CEO, MD & Executive Director4.4yrsAU$569.92k0.43%
A$ 164.1k
Gerard Criner
Member of Medical Advisory Board1.2yrsno datano data
Brad Snow
Independent Non-Executive Director1.8yrsAU$95.27kno data
William Krimsky
Chair of Medical Advisory Board1.2yrsno datano data
Bruce Thompson
Member of Medical & Scientific Advisory Boardno dataAU$1.47kno data
Stephen Selinger
Member of Medical Advisory Board1.2yrsno datano data
Jonathan Hovda
Member of Medical Advisory Board1.2yrsno datano data
Tom Takubo
Non-Executive Directorless than a yearno datano data

1.2yrs

Average Tenure

Experienced Board: RSH's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.